Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro

OBJECTIVE: To evaluate the clinical efficacy and safety of baricitinib, a Janus kinase (JAK) inhibitor, in treating patient with progressing vitiligo, and to further explore the regulation of baricitinib on melanocytes (MCs) in vitro. METHODS: Four patients with progressing vitiligo were treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Jie, Huang, Xuan, Ma, Li-Ping, Qi, Fei, Wang, Si-Nian, Zhang, Zi-Qin, Wei, Shi-Nan, Gao, Ling, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160904/
https://www.ncbi.nlm.nih.gov/pubmed/35663493
http://dx.doi.org/10.1177/15593258221105370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160904/
https://www.ncbi.nlm.nih.gov/pubmed/35663493
http://dx.doi.org/10.1177/15593258221105370

Ejemplares similares